INTRODUCTION
The cold-adapted (ca) B/Ann Arbor/l/66 (B/AA/i/66) influenza virus line was recently chosen for use in the production of ca reassortant live virus vaccines for testing in man (Maassab et a/., 1985) . The rationale behind the production of these ca reassortant vaccines is based on the experience amassed from successful triars using influenza type A ca reassortant vaccines. The optimal vaccine reassortant derives the viral genes encoding the two surface antigens, the hemagglutinin (HA) and the neuraminidase (NA), from the wild-type (wt) parent. Its other six genes are derived from the ca donor virus, and it is these genes which carry the characteristic ca, temperature-sensitive (ts), anti attenuated (att) phenotypes. Thus, for the purposes of a safe and effective influenza A virus vaccine, all that is required is the assured presence of all six nonsurface genes from the ca A/Ann Arbor/GO donor virus (for review, Maassab et al., 1985) . Laboratory studies have confirmed this phenotypic transfer to influenza B reassortant viruses by the six nonsurface genes of ca B/AA/l/66 in primary chick kidney (PCK) tissue culture and in ferrets (Maassab et al., 1986) .
Human trials have been done and are being done to extend the validity of this approach for ca influenza B reassortant vaccine viruses (Davenport et a/., 1977; Monto et al., 1982; Reeve et al., 1982; Keitel et al., 1986) . While the transfer of these phenotypes is guaranteed by the transfer of all six nonsurface genes, the total number of mutations which brings about the ca, ts, and att phenotypes and their locations in the genome are not known. It is also not clear whether these phenotypes are engendered only by the mutations that were selected by the cold-adaptation process, or by other mutations selected in an unknown manner.
Initial studies used various methods to reveal that each of the eight genes of the ca A/Ann Arbor/6/60 (A/AA/6/60) donor virus displayed some difference from the corresponding gene of the wt A/AA/6/60 virus from which it was derived (Cox et a/., 1986) . Such genomic-wide changes are also probable with the influenza B virus system since just the electrophoretic comparison of the wt and ca B/AA/l/66 viral RNA segments demonstrated that changes occur in at least six of the eight genes (Maassab et al., 1985) . Only the NA and NS ca and wt gene pairs did not migrate differently under the various conditions tested. Other studies for both influenza A and B viruses (Snyder et a/., 1987; Donabedian et al., 1987) isolated reassotiants containing all wt influenza genes except for one gene from the ca parent virus. These "single-gene" reassortants were then analyzed for expression of the ca, ts, and att phenotypes. Singlegene analysis works reasonably well for the ts and att phenotypes, but less well for the ca phenotype since the ability to replicate efficiently at 25", not a normal wt virus characteristic, can be inhibited by the presence of any wt gene that does not function well at this suboptimal temperature.
In addition, some ca viral genes may act only in concert with one or more of the other ca donor virus genes to express these phenotypes, and hence, not be identified by single-gene studies.
In an effort to determine the total extent of the sequence changes that were selected in the six nonsurface genes during the cold-adaptation of B/AA/l/66 wt virus, we sequenced both the wt and ca B/AA/l/66 strains' PB2, PBl, PA, NP, M, and NS genes. These sequence data provide a complete catalog of the nucleotide changes that existed between these two virus lines, and these changed sites were compared to other known wt influenza B virus sequences to pinpoint changes unique to ca B/AA/l/66 viral genes. These data coupled with information derived from the single-gene reassortment studies mentioned above will provide a base of knowledge for future experiments which will attempt to link particular mutations to specific phenotypes.
(See following article, Donabedian e2 a/., 1988).
MATERIALS AND METHODS

Chemicals and enzymes
Oligodeoxynucleotide primers were purchased from the University of Michigan DNA Synthesis Facility or were made by one of the authors, C. W. Naeve, with an Applied Biosystems Model 380A DNA Synthesizer. The deoxynucleoside triphosphates, dimethyldichlorosilane, y-(methacryloxy)propyltrimethoxysilane, diethyl pyrocarbonate (DEP), and sodium borohydride were purchased from Sigma Chemical Co., St. Louis, Missouri.
The 
Viruses and tissue culture
The viruses studied in these experiments were wt and ca B/AA/l/66 strains, and wt B/Melbourne/43 and B/AA/l/86 viruses.
The cold-adaptation of the wt B/AA/l/66 virus together with the passage histories for both wt and ca viruses are given in Fig. 1 . The original isolate was cultured in primary chick kidney cells from a human nasal wash sample (Maassab et a/., 1986) . It was not cloned, and therefore the starting virus was a population of individual viruses probably of related but varying individual sequences.
The production of viral stocks for the isolation of vRNA for sequencing was performed exactly as presented previously (DeBorde et al., 1986) .
Preparation of vRNA
The isolation of vRNA was performed as presented previously (DeBorde et a/., 1986) , except that the RNA from virus grown in 60-100 embryonated eggs was The dashed arrows represent a number of replicative steps as follows: %onsecutive embryonated egg passages of the wt virus pool at high dilution.
*Consecutive plaquing and egg amplification of the ca virus pool. 'Consecutive embryonated egg passages of the ca virus pool at high dilution. The bottom two boxes represent the wt and ca virus pools that were sequenced in thts paper.
B/AA/l/66 wt AND ca GENE SEQUENCES 431 resuspended in a final volume of 50 ~1, not 50 ml as erroneously stated in that paper.
End-labeling of vRNA
Purified vRNA (30 to 50 pg) and 100 &i of [32P]cytidine bis-phosphate (pCp) were dried down together in a vacuum concentrator and resuspended in 5 ~1 of 2X RNA ligase buffer, (100 mM HEPES, pH 7.5, 20 pglml BSA, 6.6 FLM ATP, 30 mM MgCl?), 1 ~1 dimethylsulfoxide, and 1 ~1 0.5 mM ATP. Thirty to thirty-five pCp ligation units of T4 RNA ligase was added, and the total volume was adjusted to 10 ~1 with H,O if necessary. The reaction was incubated at 4" overnight. Two hundred microliters of 0.3 M sodium acetate was added to the ligation mixture, followed by 600 ~1 of 95% ethanol, and the RNA was precipitated at -20" for at least 4 hr. The RNA was pelleted for 5 min in a microfuge, washed once with 70% ice-cold ethanol, pelleted once more, and dried in a vacuum concentrator. The RNA was resuspended in HZ0 and mixed with an equal volume of loading buffer (0.2X TBE, 0.2% SDS, 20% sucrose, and 0.01% bromphenol blue).
Isolation of individual vRNA segments
For the chemical sequencing reactions, the purified and [3zP]pC:P 3' end-labeled vRNA was separated into its eight segments on a 3% polyacrylamide gel in 1 X TBE, (0.09 M Trizma base, 0.09 M boric acid, and 2 mM Na,EDTA) (Peacock and Dingman, 1968) with 0.01% sodium dodecyl sulfate (SDS). This level of SDS still protected the RNA from any contaminating RNases during the long electrophoretic run, but did not preclude visualization of the RNA with ethidium bromide. These conditions separated all segments except RNAs 4 and 5 (NP and HA). To separate these two RNAs, 6 M urea was added to the above gel. The RNA was electrophoresed at 37" for 16 hr at 200 V, constant voltage for the nondenaturing gel, and at 37" for 21 hr at 240 V, constant voltage for the 6 M urea gel. A\,fter electrophoresis the vRNA segments were visualized by immersing the gel in 1 liter of 1 X TBE buffer containing O.Ol% SDS and 1 pg/ml ethidium bromide for 25 min at room temperature. The gel was then removed from the ethidium bromide solution, rinsed with 1 X TBE buffer, and placed on a sheet of plastic wrap on a uv transilluminator. The desired RNA was excised from the gel with little or no excess gel material. The end-labeled vRNA segments were then eluted from the gel slices using an International Biotechnologies, Inc. (New Haven, CT), unidirectional electroeluter.
The running buffer was 0.5X TBE buffer plus 0.01% sarcosine.
The high salt retention buffer was 3.0 M sodium acetate with 0.03% sarcosine and 0.01% bromphenol blue. Elution proceeded at 100 V, constant voltage, for I-hr intervals. The smaller segments, NS and M, were completely eluted in 1 hr; NP, HA, and NA segments took 2 to 3 hr; and the three polymerase segments, PB2, PBl and PA took 3 to 4 hr. Completion of elution was monitored by Cerenkov counting of the original gel slice and hourly samples. Recovery was 70 to 90% of the original sample. The isolated vRNA segments were precipitated at -20" overnight with 3 vol of 95% ethanol.
Chain-termination sequencing reactions and gels
These procedures, including the use of TdT to eliminate ambiguities, were performed exactly as described previously (DeBorde et al., 1986) . Only one compression area was encountered. It was in the PB2 gene and was resolved by running the standard sequence reaction products on a gel that was a 7 M urea, 8% polyacrylamide gel modified by the addition of 40% deionized formamide (Martin, 1987) . To determine the wt and ca sequences, the sequencing reaction products were run side by side on the same electrophoretic gel. Several independent runs, with and without TdT enzyme treatment, were performed for each primer.
Chemical sequencing reactions and gels
These procedures were taken from Peattie (1979) and followed exactly, including the electrophoresis and autoradiography procedures. Recommendations given in Peattie (1979) for the safe use and disposal of sodium borohydride, aniline, DEP, and hydrazine were followed.
Sequence analysis programs
All sequence analyses, comparisons, manipulations, and calculations were performed using the programs developed by Queen and Korn (1984) ... AUG GGG AAU GCA GUA UUG GCA GGC UUU CUC GUU AGU GGC AAG UAU GAU CCG GAU CUU GGA I% irk h ii; ii; G.i &ii Eilir ini k iiri G kE, &t 62 fi kin ( GUU ACA GGA UGU GCA AUG GUR GAU CCA ACA AAU GGG CCA UUA CCC GAA MU AAU GAG CCG AGU GCC UAU GCA CAA UUG GAU UGC GUU CUG GAG GCU UUG GAU AGA AUG ( references).
Both methods were applied directly to vRNA isolated from purified virus. Thus, the determined sequences represent consensus sequences based on the population of vRNA segments. The chemical sequencing method identified the first 50-90 nucleotides of each gene and overlapped the first primer-determined sequence by at least 15 nucleotides. Therefore the sequences on the 5'side of the first primer positions were determined exclusively by the direct chemical sequencing method. Oligodeoxynucleotide primers were usually 15 nucleotides in length and the sequence from each preceding primer overlapped the next determined sequence by at least 15-20 nucleotides.
Their positions in the sequences are shown by underlining of the wt cRNA sequence of each gene. Only the differences are presented for the ca RNA and predicted ca polypeptide sequences, and these are shown above and below the corresponding wt sequences, respectively. The results for each individual gene are presented below. 
PB2 gene
Both wt and ca influenza B/AA/l/66 PB2 genes were 2396 nucleotides long. They encoded polypeptides of 770 amino acids. The first methionine codon in the open reading frame began at position 24 (in from the 5' end of the cRNA) and the first termination codon began at position 2334. A consecutive run of five adenosine residues began at position 2375 and was the probable polyadenylation site. The predicted wt and ca PB2 proteins had molecular weights of 88,035 and 88,072 Da, and both had a net charge of +24.5 at pH 7.0, with no large hydrophilic domains. The ca PB2 gene varied from the wt gene by 26 base substitutions.
Of these changes, 24 occurred in the coding region. Only 4 of these changes were reflected in amino acid changes. Of these 4 changes, 1 was unique to the ca PB2 gene, and 3 were indentical to sequences noted in other wt influenza B virus PB2 genes (B/Melbourne/43 and B/AA/i/86), see Fig. 8 . A reassot-tant containing the PB2 gene of ca B/AA/l/66 virus, and all other genes from a wt virus, B/Houston/76, is non-&, non-ca, and as virulent as the wt virus (Donabedian et al., 1987) . Hence, the PB2 gene of the ca donor virus apparently contributed to none of the three phenotypes of interest in an independent manner. It is possible that it may be involved in any of these phenotypes in combination with one or more other ca B/AA/l/66 genes, especially those involved in the replication complexes.
PB1 gene
The general characteristics of the influenza B PBl gene have been previously described by Kemdirim and (Fig. 8) .
The primer sequenc'e starting at position 221 is actually ACC ACA AGC AGT GAA. Thus its sequence varies from that of the wt sequence at position 232, and from that of the ca sequence at position 22 1. This primer was made based on B/Lee/40 sequences, but despite the one nucleotide difference for each B/AA/l/66 virus, it worked well. (All other primers which were made prior to actual B/AA/l/66 viral sequence knowledge and which were later shown to vary by even one nucleotide, would not function.) , 1986) . Thus, at this time only the two changes in the M, protein and possibly one in the 2 ORF appeared to be unique to the cold-adapted virus (Fig. 8) .
NS gene
The NS gene had the lowest number of changes between wt and ca Em/AA/l/66 viruses. Only two base substitutions were present, both exclusively in the NS, coding region, and neither of these resulted in amino acid changes in the INS, protein. One change, at position 80, occurred in the 5'-donor-splice region, but it was an acceptable change based on the consensus signal from Mount (1!382). Unless the wt NS gene itself was inherently attenuating, cold-adapted, or temperature-sensitive, we wcluld predict that this gene contributes little to the overall phenotypes of the ca B/AA/l/ 66 virus.
Unique changes of ca B/AA/ 1 I66 virus
The total nucleotide and amino acid changes between the six nonsurface genes of wt and ca B/A/VI/ 66 viruses are given in Fig. 8 showing a comparison to the corresponding site in other known influenza B sequences. Except for those changes which occur in the noncoding regions of the genes, the sites are presented in their codon, with their encoded amino acid. Where possible the changes have been divided into groups: (1) those nucleotide changes that were unique to ca B/AA/l/66 virus (the top group for each gene), and (2) those changes that were also seen in one or more other wt viruses (the bottom two groups for each gene). Sequences for PB2, NP, M, and NS genes have been determined from viral isolates that occurred both earlier and later in time than the B/AA/l/66 viruses. Only one other sequence for the PBl gene has been reported to which B/AA/l/66 viral PBl sequences can be compared, and it was determined from an earlier virus isolate (B/Lee/40).
Therefore, the group of changes, PBl positions 14-21, may contain some unique ca nucleotide changes even though no amino acid change results. The PA gene has two other PA sequences to which it can be compared, but both genes are from later viral isolates. The nucleotide changes that result in amino acid changes are enclosed in boxes. Out of 15 unique nucleotide changes, 10 of these resulted in 1 1 unique amino acid changes. (One change in the M gene caused a unique amino acid change both in M, and in the 2 ORF.) The 89 remaining nonunique nucleotide changes resulted in only 15 additional amino acid changes. Table 1 presents a summary of the total numbers of nucleotide and amino acid changes that were selected in the cold-adaptation of wt B/AA/l/66 virus. The lack of changes occurring in the 5'-noncoding regions was probably not indicative of an active conservation of sequence, since overall, only one or two changes would have been predicted by the observed, average rate of change: i.e., 199 nucleotides/5'-noncoding region X 0.0094 changes/nucleotides = 1.88 changes/ 5'-noncoding region. More disturbing is the lack of change in the NS gene. While all other genes range around 0.1 change/nucleotide, that of the NS gene is fivefold less. The reasons for this difference are not known. Only 26 amino acid changes are predicted to occur from a total of 105 nucleotide changes. This indicates a high degree of functional constraint, since on a random basis, 105 changes should result in approximately two-thirds as many amino acid changes, 440 DE BORDE ET AL. i.e., 71. Of the 26 total amino acid differences that exist between the six pairs of wt and ca genes, only 1 1 are unique to ca B/AA/l/66 virus.
Total changes
DISCUSSION
As seen in Fig. 1~ the initial CK, isolate of wt B/AA/l/66 virus had not been cloned by plaquing prior to the cold-adaptation process. Therefore, it was most likely a pool of viruses whose individual genomic sequences were highly related, but to some extent different for each virus. This assumption is based on the data of Par-vin and colleagues (1986) which give a mutation rate of 1.5 X 1 Oe5 mutations/nucleotide/generation for influenza A virus. At this rate of mutation, they estimate that every virion in a virus pool will vary by an average of one mutation per genome after five generations. The further removed in time a virus line is from its last plaquing step, the more diverse its individual viruses. Thus, when a virus pool is sequenced directly using either dideoxynucleotide chain-termination or chemical methods and purified vRNA, it is a consensus sequence that is determined and not the absolute sequence of a particular virus.
It should be noted that mutations which occur during every generation of the virus become fixed in the dominant line (and hence appear in the consensus sequence) only if they are in the infecting virus selected by a plaquing step, or if they confer a very great growth advantage compared to the standard population. Mutations which confer growth advantages at suboptimal temperatures have a better chance of predominating in the population in the cold adaptation process, and hence a better chance of becoming selected during plaquing. In addition to these selected mutations, nonlethal mutations may also be selected at random by each plaquing step. Thus, in comparing the final two populations of ca and wt B/AA/l/66 viruses, the sequence changes that exist will primarily represent (1) sequence differences existing between the particular wt virus, that was the progenitor of the ca virus, and the wt virus consensus sequence, (2) cold-selected mutations (these differences may have already existed in the wt pool or have occurred spontaneously during the cold-adaptation process and then been selected, and (3) other spontaneous nonlethal mutations that occur randomly with each generation, and become fixed by the mechanism of plaquing as part of the final ca virus consensus sequence. Thus the cold-adaptation procedure and the plaquing procedures not only selected changes that resulted in the ca, ts, and att phenotypes, but also at the time of the first plaquing, a particular individual virus was selected from the mixed wt pool that would inherently contain a number of sequence differences from the consensus sequence of the wt virus pool, which probably have no bearing on these three phenotypes. It is conceivable that a change in the nucleic acid sequence might enable the expression of the ca phenotype without a corresponding amino acid change, but it is more likely that the cold-adaptation procedure operates by selecting viruses whose proteins function better at the low temperature. Thus, those nucleotide changes that were cold-selected should most likely be reflected in an amino acid change. This condition certainly fits the set of 15 unique nucleotide changes, since they were responsible for 11 of the 26 total amino acid changes.
The other 15 amino acid changes were encoded by a subset of the other 90 nonunique nucleotide changes. While it is impossible to go back now and determine which changes occurred at which stage in the cold adaptation process, it is very likely that a large part of the unique changes represented cold-selected changes, while most nonunique changes represented nonlethal random site differences that existed between the wt consensus
